Skip to content

Ketamine

How Fast Does Ketamine Work for Depression?

Ketamine may begin reducing depressive symptoms within hours, with effects often assessed around 24 hours. The timing, strength and duration of improvement vary, and one treatment is not usually the whole treatment plan.

Written by Dr. Chi Hung Au, Psychiatrist

4 min read

How quickly can ketamine work for depression?

Ketamine is unusual among antidepressant treatments because improvement may sometimes be detected within hours. In research, substantial antidepressant effects are often assessed around 24 hours after treatment. However, not everyone responds to the first treatment, and a rapid average improvement in a clinical trial does not mean every patient will feel dramatically better the same day.

Some people first notice less emotional heaviness, fewer negative thoughts or a greater ability to function. Others improve more gradually over multiple treatments, and some do not benefit. An individualized psychiatric assessment is needed to determine whether ketamine or esketamine may be appropriate.

Can ketamine really work within hours?

Yes, it can. A reported 2026 JAMA Psychiatry meta-analysis of 26 randomized trials involving 1,166 participants found that improvement with intravenous (IV) ketamine was detectable at approximately four hours, remained evident at 24 hours and persisted at later measured time points after one infusion. In patient-friendly terms, participants receiving ketamine improved more, on average, than participants receiving a comparison treatment.

These results show that an antidepressant effect can begin quickly. They do not establish that everyone will notice a meaningful change within four hours, nor do they predict how long an individual’s improvement will last. The findings also concern IV ketamine and should not automatically be treated as evidence for every route of administration. NeuroLinks does not provide IV ketamine.

When is the strongest effect usually seen?

Many ketamine studies identify a prominent antidepressant effect at around 24 hours. A 2023 review in The Lancet reported that IV ketamine studies often found their largest response at that point, with the average effect decreasing over the following week after a single treatment.

Twenty-four hours is a research assessment point, not a biological deadline. Feeling little change the next morning does not by itself establish that treatment has failed. Symptoms may shift at different rates, and clinicians generally assess change over time rather than relying on one moment or one subjective impression.

How quickly does intramuscular (IM) ketamine work?

Intramuscular (IM) racemic ketamine may also have a rapid antidepressant effect. Small studies have reported improvement within approximately two hours, with prominent effects around 24 hours. This early evidence includes a small 2014 head-to-head study and a placebo-controlled pilot comparing administration routes.

How fast does intranasal esketamine work?

Esketamine is the S-enantiomer of ketamine and is administered as a nasal spray. It is not the same product as racemic ketamine. Evidence reviewed in The Lancet indicates that reductions in depressive symptoms can occur within one day when intranasal esketamine is used with an oral antidepressant in studied populations.

As with racemic ketamine, response varies and repeated treatment is commonly studied. Available evidence does not justify claiming that esketamine is faster or more effective than IM ketamine for every patient without reliable head-to-head research.

Does a fast response mean one treatment is enough?

Usually, rapid onset and duration are separate questions. A person may improve soon after one treatment but find that the effect fades. The 2023 Lancet review noted that the average effect after one IV infusion decreased over the following week, although duration varied among studies.

Clinical plans may involve an initial series and later reassessment or maintenance, depending on the treatment, response and tolerability. The appropriate number and timing of treatments cannot be determined from a general article and should not be inferred from another patient’s experience.

  • Onset: when improvement first becomes detectable
  • Peak or prominent effect: when symptom change appears strongest
  • Duration: how long improvement continues
  • Treatment course: how many treatments are used and how response is reassessed

What should I expect after the first treatment?

Do not assume that temporary sensations during treatment are the antidepressant response. Ketamine and esketamine can cause short-term effects such as dizziness, sleepiness, nausea, altered perception or dissociation. Clinical monitoring is important, and any unexpected or concerning symptoms should be reported to the treating team.

A useful assessment looks beyond whether you felt different immediately. Changes in mood, interest, negative thinking, sleep and everyday functioning over subsequent days can provide a fuller picture. Do not change prescribed medication or a treatment plan without discussing it with your clinician.

NeuroLinks offers psychiatrist-led assessment and provides IM racemic ketamine and intranasal esketamine in Nanaimo for appropriately selected patients from Vancouver Island and elsewhere in British Columbia. Contact NeuroLinks to ask about assessment or referral without submitting confidential clinical details through public website forms.

References

  1. Steven Marwaha, Edward Palmer, Trisha Suppes, Emily Cons, Allan H Young, Rachel Upthegrove. Novel and emerging treatments for major depression. The Lancet 401(10371):141-153 (2023)

This article is educational and does not replace an individual psychiatric assessment. Medical review is recorded in the article details when completed.